Inventor · disambiguated record
Mark Stroud
Also filed as: STROUD MARK · STROUD MARK R
11 granted patents·9 pending applications·132 citations·filing 1988–2024
90Inventor score
Top patents by PatentIndex Score
20 records- 0190US11559580B1Tissue-homing peptide conjugates and methods of use thereofBLAZE BIOSCIENCE INC·Filed 2021·Granted Jan 24, 2023·4 cites·20 claims
- 0287US11866466B2Tumor homing and cell penetrating peptide-immuno-oncology agent complexes and methods of use thereofBLAZE BIOSCIENCE INC·Filed 2018·Granted Jan 9, 2024·3 cites·22 claims
- 0387US11013814B2Cartilage-homing peptide conjugates and methods of use thereofBLAZE BIOSCIENCE INC·Filed 2018·Granted May 25, 2021·3 cites·25 claims
- 0481US5421733ASynthesis of Lex ; dimeric Lex (difucosyl Y2 ; III3 FucV3 FucnLc6 Cer); sialylated forms thereof; and analogues thereofBIOMEMBRANE INST·Filed 1991·Granted Jun 6, 1995·22 cites·10 claims
- 0580US6133239ACarbohydrate ligands (myelorollin) that cause E-selectin dependent cell rolling and adhesion under dynamic flow systemBIOMEMBRANE INST·Filed 1996·Granted Oct 17, 2000·53 cites·22 claims
- 0678US2025115648A1Chlorotoxin conjugates and methods of use thereofBLAZE BIOSCIENCE INC·Filed 2024·Application pending·0 cites
- 0774US2024309058A1Tumor homing and cell penetrating peptide-immuno-oncology agent complexes and methods of use thereofBLAZE BIOSCIENCE INC·Filed 2023·Application pending·0 cites
- 0871US12048750B2Tissue-homing peptide conjugates and methods of use thereofBLAZE BIOSCIENCE INC·Filed 2022·Granted Jul 30, 2024·0 cites·18 claims
- 0965US2020188536A1Chlorotoxin conjugates and methods of use thereofBLAZE BIOSCIENCE INC·Filed 2019·Application pending·0 cites
- 1065US2021260205A1Cartilage-homing peptide conjugates and methods of use thereofBLAZE BIOSCIENCE INC·Filed 2021·Application pending·0 cites
- 1164US6294523B1Extended type 1 chain glycosphingolipids as tumor-associated antigensBIOMEMBRANE INST·Filed 1999·Granted Sep 25, 2001·12 cites·18 claims
- 1256US6083929AExtended type 1 chain glycosphingolipids as tumor-associated antigensBIOMEMBRANE INST·Filed 1993·Granted Jul 4, 2000·17 cites·9 claims
- 1348US2021171589A1Truncated cartilage-homing peptides and peptide complexes and methods of use thereofBLAZE BIOSCIENCE INC·Filed 2019·Application pending·0 cites
- 1447US6130205AMethod for determining susceptibility to Escherichia coli urinary tract infections, method for diagnosing secretors and nonsecretors, and method and medicament for preventing Escherichia coli urinary tract infectionsUNIV WASHINGTON·Filed 1995·Granted Oct 10, 2000·12 cites·32 claims
- 1545US2003186935A1MyeloglycanFiled 2003·Application pending·0 cites
- 1644US2005245479A1MyeloglycanHANDA KAZUKO·Filed 2003·Application pending·0 cites
- 1742US2003064956A1MyeloglycanFiled 2002·Application pending·0 cites
- 1842US2016096869A1Chlorotoxin conjugates and methods of use thereofBLAZE BIOSCIENCE INC·Filed 2015·Application pending·0 cites
- 1936US5030723ALong-chain glycolipid structureBIOMEMBRANE INST·Filed 1988·Granted Jul 9, 1991·6 cites·2 claims
- 2029US5876715AAntibodies that bind novel carbohydrate ligands (myelorollins) that cause E-selectin dependent cell rolling, and uses thereofBIOMEMBRANE INST·Filed 1996·Granted Mar 2, 1999·0 cites·6 claims
Join the waitlist — get patent alerts
Get an alert when Mark Stroud files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →